avex pharma semaglutide Semaglutide Receives FDA Approval for Treatment of MASH Denmark-based #NovoNordisk, makers of popular

Clinical data shows that semaglutide, the active ingredient in Ozempic and Wegovy, produces an average body weight reduction of 14.9% over 68 weeks

Until now, Wegovy has only been available in an injectable form

doi: 10.3389/FNINS.2022.824054/XML/NLM 80 MuayadJLoyaAHussainZSChauhanMZAlsoudiAFDe FrancescoTet al

Not all weight loss is equal, and this is where body composition becomes crucial

Am J Clin Nutr (2009) 89(2):693S6S.10.3945/ajcn.2008.26947A 2 StablerSP

This type of fat is metabolically active and can lead to insulin resistance, elevated inflammation, and higher cholesterol levels, all of which increase the risk of heart disease